Mindray is extremely committed to bringing cutting-edge technology to the global ultrasound market
Mountain View, Calif. (PRWEB) August 17, 2016
Following the recent announcement of the appointment of Glen McLaughlin, PhD, as worldwide chief product officer, Ultrasound, Shenzhen Mindray Bio-Medical Electronics Co.,Ltd (Mindray), a leading global developer, manufacturer and marketer of medical devices, has designated its Silicon Valley headquarters as the North American Technology Innovation Center. McLaughlin is based out of this Mountain View, California location and will lead development and marketing of Mindray’s premium and high-end ultrasound products for the mQuadro and ZONE Sonography® Technology (ZST) lines.
“Mindray is extremely committed to bringing cutting-edge technology to the global ultrasound market,” said McLaughlin. “With world class resources located in Silicon Valley, establishing a technology innovation center for this key modality in the area demonstrates the company’s intent to access these valuable resources in order to fulfill its goal to provide state-of-the-art ultrasound technology.”
McLaughlin and his team were the pioneers in developing ZST, a next generation ultrasound technology. ZST enables imaging developments such as Advanced Acoustic Acquisition™, a software acquisition technique that breaks with traditional line-by-line imaging and instead uses large zones to acquire 90 percent more echo data at speeds of up to 10 times faster than conventional systems. The results are crystal clear images with exceptional temporal accuracy bringing diagnostic confidence to all imaging challenges.
ZST also drives Dynamic Pixel Focusing™ where, automatically, every pixel is optimally focused in every frame, at every depth and every time. No other technology eliminates manual focal zones and reveals structural clarity from the skin line to depths of up to 40 centimeters (cm), whether the smallest of neonates or the largest of bariatric patients.
“Now with the feature rich Mindray mQuadro technology available, we have excellent opportunities to leverage it along with ZST,” said McLaughlin. “This will enable us to expand our offerings and applications. We are excited about the future of our combined technologies and look forward to working with our valued customers to bring even better solutions to their ultrasound imaging needs.”
Mindray is a leading developer, manufacturer and marketer of medical devices worldwide. Its global headquarters are located in Shenzhen, China, North American headquarters in Mahwah, New Jersey, a technology innovation center in Silicon Valley, California and multiple sales offices in major international markets. From the main manufacturing and engineering base in China, the company supplies, through a worldwide distribution network, a broad range of products across three primary business segments, which include patient monitoring and life support, in-vitro diagnostics and medical imaging systems. For more information, please visit http://www.mindray.com
ZONARE is a wholly owned subsidiary of Mindray located in Silicon Valley, Calif. As a Mindray Center of Innovation, the company is solely dedicated to ultrasound excellence through its innovative, award-winning next generation technology which provides the platform for the company’s Living Technology designed to meet its customers evolving imaging needs. The patented design and ZONE Sonography® Technology (ZST) architecture of the Z.One PRO and ZS3 platforms deliver high-end image quality and clinical versatility. For more information, please visit http://www.zonare.com